Abstract
Isoprostanes (IPs) are a recently discovered complex group of stable prostaglandin-like molecules formed by the free radical-catalyzed peroxidation of polyunsaturated fatty acids (1). F2-isoprostanes (F2-IPs) are formed by the oxidation of arachidonic acid and can be classified into four major regioisomeric groups, and characterized by a cis-oriented side chain (2). Because the majority of arachidonic acid is currently esterified in phospholipids, F2-IPs are initially formed esterified and are subsequently released in the free form following cleavage by phospholipase A2 (3). The presence of F2-IPs in vivo was initially reported by Morrow et al. (1). The levels of one of the abundant isomers, 8-epi-PGF2α, was shown to increase by up to 200-fold in established animal models of oxidative injury (4). High levels of F2-IPs can disrupt the physicochemical integrity of cell membranes (3), but more importantly can exert significant pharmacological activity. 8-epi-PGF2α is a potent vasoconstrictor acting on the renal, pulmonary, and retinal vasculatures (1,5,6), modulates platelet aggregation (7), and is involved in the activation of intracellular signaling (8). Isoprostanes can also be formed enzymatically by the cyclooxygenase pathway in platelets, monocytes and vascular smooth muscle (9–11).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Morrow, J. D., Hill, K. E., Burk, R. E., Nammour, T. M., Badr, K. F., and Roberts, L. J. II (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalysed mechanism.Proc. Natl. Acad. Sci. USA 87, 9383–9387.
Morrow, J. D., Harris, T. M., and Roberts, L. J. II (1990) Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184, 1–10.
Morrow, J. D., Awad, J. A., Boss, H. J., Blair, I. A., and Roberts, L. J. II (1992) Noncyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA 89, 10,721–10,725.
Awad, J. A., Morrow, J. D., Hill, K. E., Roberts, L. J. II, and Burk, R. F. (1994) Detection and localization of lipid peroxidation in selenium and vitamin E-deficient rats using F2-isoprostanes. J. Nutr. 124, 810–816.
Banerjee, M., Kang, K. H., Morrow, J. D., Roberts, L. J. II, and Newman, J. H. (1992) Effects of a novel prostaglandin, 8-epi-PGF2α, in rabbit lung in situ. Am. J. Physiol. 263, H660–H663.
Lahaie, I., Hardy, P., Hou, X., Hassessian, H., Asselin, P., Lachapelle, P., et al. (1998) A novel mechanism for vasoconstrictor action of 8-isoprostaglandin-F2α on retinal vessels. Am. J. Physiol. 274, R1406–R1416.
Pratico, D., Smyth, E. M., Violi, F., and FitzGerald, G. A. (1996) Local amplification of platelet function by 8-epi-PGF2α is not mediated by thromboxane receptor isoforms. J. Biol. Chem. 271, 14,916–14,924.
Kunapuli, P., Lawson, J. A., Rokach, J. A., Meinkoth, J. L., and FitzGerald, G. A. (1998) Prostaglandin F2α and the isoprostane 8,12-iso-isoprostane F2α-III, induce cardiomyocyte hypertrophy: differential activation of downstream signaling pathways. J. Biol. Chem. 273, 22,442–22,452.
Pratico, D., Lawson, J. A., and FitzGerald, G. A. (1995) Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2α. J. Biol. Chem. 270, 9800–9808.
Pratico, D. and FitzGerald, G. A. (1996) Generation of 8-epiprostaglandin F2α by human monocytes: discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J. Biol. Chem. 271, 8919–8934.
Jourdan, K. B., Mitchell, J. A., and Evans, T. W. (1997) Release of isoprostanes by human pulmonary artery in organ culture: a cyclo-oxygenase and nitric oxide dependent pathway. Biochem. Biophys. Res. Commun. 233, 668–672.
Gopaul, N. K., Änggård, E. E., Mallet, A. I., Betteridge, D. J., Wolff, S. P., and Nourooz-Zadeh, J. (1995) Plasma 8-epi-PGF2α levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 368, 225–229.
Gopaul, N. K., Manraj, M. D., Hébé, A., Lee Kwai Yan, S., Johnston, A., Carrier, M. J., et al. (2001) Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia 44, 706–712.
Davi, G., Ciabattoni, G., Consoli, A., Mezzetti, A., Falco, A., Santarone, S., et al. (1999) In vivo formation of 8-iso-prostaglandin F2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99, 224–229.
Davi, G., Alessandrini, P., Mezzetti, A., Minotti, G., Bucciarelli, T., Constantini, F., et al. (1997) In vivo formation of 8-epi-prostaglandin F2α is increased in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 17, 3230–3235.
Pratico, D., Iuliano, L., Basili, S., Ferro, D., Camastra, C., Cordova, C., et al. (1998) Enhanced lipid peroxidation in hepatic cirrhosis. J. Invest. Med. 46, 51–57.
Pratico, D., Lee, V. M. Y., Trojanowski, J. Q., Rokach, J., and FitzGerald, G. A. (1998) Increased F2-isoprostanes in Alzheimer’s disease: Evidence of enhanced lipid peroxidation in vivo. FASEB J. 12, 1777–1783.
Delanty, N., Reilly, M., Pratico, D., Lawson, J. A., McCarthy, J. F., Wood, A. E., et al. (1997) 8-epi-PGF2α generation during coronary reperfusion: A potential quantitative marker of oxidant stress in vivo. Circulation 95, 2492–2499.
Reilly, M., Pratico, D., Lanken, P., Delanty, N., Rokach, J., Lawson, J. A., et al. (1998) Isoprostanes in the assessment of oxidant stress in vivo, in Molecular and Cellular Basis of Inflammation (Serhan, C. N. and Ward, P. A., eds.), Humana, Totowa, NJ, pp. 127–139.
Palmer, A. M., Thomas, C. R., Gopaul, N. K., Dhir, S., Änggård, E. E., Poston, L., et al. (1998) Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocin-diabetic rat. Diabetologia 41, 148–156.
Laight, D. W., Desai, K. M., Gopaul, N. K., Änggård, E. E., and Carrier, M. J. (1999) F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E. Eur. J. Pharmacol. 377, 89–92.
Kengatharan, M., Gopaul, N. K., Dhir, S., Pettersson, K., Carrier, M., and Änggård, E. E. (1997) Inhibition of 8-epi-prostaglandin F2α production by vitamin E is associated with the reversal of endothelial dysfunction in the cholesterolfed rabbit. Br. J. Pharmacol. 122(SS), P155.
Chowienczyk, P. J., Brett, S. E., Gopaul, N. K., Meeking, D., Marchetti, M., Russell-Jones, D. L., et al. (2000) Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with Type II diabetes. Diabetologia 43, 974–977.
Morrow, J. D., Frei, B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Stauss, W. E., et al. (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N. Engl. J. Med. 332, 1198–1203.
Wendelborn, D. F., Morrow, J. D., and Roberts, L. J. II (1990) Quantification of 9α,11β-prostaglandin F2 by stable isotope dilution mass spectrometric assay. Methods. Enzymol. 187, 51–62.
Li, W., Lawson, J. A., Reilly, M., Rokach, J., and FitzGerald, G. A. (1999) Quantitative analysis of F2-isoprostanes by HPLC/tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 96, 13,381–13,386.
Mori, T. A., Croft, K. D., Puddey, I. B., and Beilin, L. J. (1999) An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography mass spectrometry. Anal. Biochem. 268, 117–125.
Bachi, A., Zuccato, E., Baraldi, M., Fanelli, R., and Chiabrando, C. (1996) Measurement of urinary 8-epi-prostaglandin F2α, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers. Free Rad. Biol. Med. 20, 619–624.
Gopaul, N. K., Halliwell, B., and Änggård, E. E. (2000) Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet. Free Rad. Res. 33, 115–127.
Gopaul, N. K., Zacharowski, K., Halliwell, B., and Änggård, E. E. (2000) Evaluation of the postprandial effects of a fast-food meal on human plasma F2-isoprostane levels. Free Rad. Biol. Med. 28, 806–814.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Gopaul, N.K., Änggård, E.E. (2003). Measurement of 8-epi-PGF2α as a Marker of Lipid Peroxidation In Vivo by Immunoaffinity Extraction and Gas Chromatography-Mass Spectrometry. In: Winyard, P.G., Willoughby, D.A. (eds) Inflammation Protocols. Methods in Molecular Biology, vol 225. Humana Press. https://doi.org/10.1385/1-59259-374-7:329
Download citation
DOI: https://doi.org/10.1385/1-59259-374-7:329
Publisher Name: Humana Press
Print ISBN: 978-0-89603-970-4
Online ISBN: 978-1-59259-374-3
eBook Packages: Springer Protocols